Expert second opinions for pulmonary valve disease. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Pulmonary Valve Disease is most commonly seen in adults who had childhood repairs for congenital heart disease (especially Tetralogy of Fallot). If you are facing a decision about pulmonary valve disease, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Pulmonary valve disease is most commonly seen in adults who had childhood repairs for congenital heart disease (especially Tetralogy of Fallot). Chronic pulmonary regurgitation leads to right ventricular dilation and dysfunction, eventually requiring valve replacement.
Timing of pulmonary valve replacement is critical — too late and RV dysfunction becomes irreversible. Transcatheter pulmonary valve replacement (TPVR) has expanded options for patients with suitable anatomy, but not all conduits are amenable to transcatheter approaches. Expert evaluation determines the optimal timing and method.
Surgery for pulmonary valve disease depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Timing of pulmonary valve replacement is critical — too late and RV dysfunction becomes irreversible. Transcatheter pulmonary valve replacement (TPVR) has expanded options for patients with suitable anatomy, but not all conduits are amenable to transcatheter approaches. Expert evaluation determines the optimal timing and method.
Operative mortality for pulmonary valve disease-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for pulmonary valve disease depends on anatomy, comorbidities, age, and personal goals. Timing based on RV size and function parameters. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.